LARIMAR THERAPEUTICS INC (LRMR) Stock Balance Sheet
NASDAQ:LRMR - Nasdaq - US5171251003 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 33.22M | 26.75M | 26.82M | 70.10M | 68.15M | |||
| Marketable Securities | 150.24M | 60.04M | 91.60M | 0.00 | 24.49M | |||
| Receivables | 1.05M | N/A | 0.00 | 208.00K | N/A | |||
| Other Current Assets | 10.80M | 3.38M | 2.31M | 1.90M | 5.31M | |||
| Total Current Assets | 195.30M | 90.17M | 120.74M | 72.20M | 97.95M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.72M | 3.76M | 3.69M | 4.46M | 4.98M | |||
| Other Non-Current Assets | 1.20M | 2.00M | 1.98M | 2.01M | 1.76M | |||
| Total Non-Current Assets | 4.92M | 5.76M | 5.67M | 6.46M | 6.73M | |||
| TOTAL ASSETS | 200.22M | 95.94M | 126.41M | 78.67M | 104.69M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 21.93M | 8.22M | 9.02M | 7.19M | 6.36M | |||
| Accounts Payable | 2.42M | 1.28M | 1.69M | 1.66M | 2.63M | |||
| Total Current Liabilities | 24.36M | 9.51M | 10.71M | 8.85M | 8.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.06M | 4.71M | 4.80M | 5.41M | 6.00M | |||
| Total Non-Current Liabilities | 4.06M | 4.71M | 4.80M | 5.41M | 6.00M | |||
| TOTAL LIABILITIES | 28.41M | 14.21M | 15.50M | 14.25M | 14.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -269.16M | -188.55M | -151.60M | -116.25M | -65.61M | |||
| Additional Paid In Capital | 440.76M | 270.15M | 262.50M | 180.65M | 155.29M | |||
| Common Shares | 64.00K | 43.00K | 43.00K | 18.00K | 15.00K | |||
| Other Shareholders' Equity | 148.00K | 81.00K | -31.00K | 0.00 | 1.00K | |||
| Shares Outstanding | 63.81M | 43.91M | 43.27M | 17.71M | 15.37M | |||
| Tangible Book Value per Share | 2.69 | 1.86 | 2.56 | 3.64 | 5.84 | |||
| Total Shareholders' Equity | 171.81M | 81.72M | 110.90M | 64.41M | 89.69M | |||
| TOTAL LIABILITIES AND EQUITY | 200.22M | 95.94M | 126.41M | 78.67M | 104.69M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.02 | 9.49 | 11.28 | 8.16 | 10.89 | |||
| Return On Assets (ROA) | -40.26% | -38.51% | -27.97% | -64.37% | -40.58% | |||
| Return On Equity (ROE) | -46.91% | -45.21% | -31.88% | -78.61% | -47.36% | |||
All data in USD , ROIC based on taxRate of 0.21